Clinical Trials Compliance Research and Development Safety 
Cannabis Law Report
MAY 29, 2022
Earlier this month, Senators Brian Schatz (D-HI) and Cory Booker (D-NJ) sent a letter to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) urging both agencies to advance research on the therapeutic effects of psychedelic drugs. [1] Recent Regulatory Developments. Challenges.
Cannabis Law Report
MARCH 29, 2020
How are companies setting the standards for quality and how are we researching consumers to understand their experiences with cannabis products accurately and ethically? This post explores the manufacturing and research standards to consider when conducting research studies with cannabis. . . Product Quality in Manufacturing.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
NOVEMBER 19, 2021
“These patent filings are critical components of PsyBio’s corporate development strategy. “These patent filings are critical components of PsyBio’s corporate development strategy. PsyBio remains interested in developing the intellectual property landscape within the psycho-targeted development drug arena.
Cannabis Law Report
JULY 28, 2021
MAPS Public Benefit Corporation (MAPS PBC) catalyzes healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics prioritizing public benefit above profit. Support Regulatory Affairs in the planning, development, and publishing of submissions.
Cannabis Law Report
JANUARY 24, 2022
Company is on track to announce interim data in mid-2022 from its Phase 2 clinical trial for lead kidney precision medicine product candidate GFB-887. Tucker has successfully advanced several programs through clinical development and regulatory approval. CAMBRIDGE, Mass.–(BUSINESS Dr. Tucker. “I
Cannabis Law Report
JUNE 2, 2021
Aggregate testing results will be reported to the director of the summer camp via safeCircle’s integration with CLEARED4, the Company’s pooled surveillance testing program partner, through CLEARED4’s smartphone-based online health safety management and reporting solution. Testing will be conducted from mid-June through end-July.
Cannabis Law Report
OCTOBER 26, 2019
ii Non-clinical studiesAlthough the use of animals in research is separately regulated by each state and territory, all require compliance with the Australian Code for the Care and Use of Animals for Scientific Purposes (Animal Code). One such circumstance is a clinical trial.
Expert insights. Personalized for you.
52 
Let's personalize your content